Evidence map›Paper›PMID 42146199›Full record

ArticleACS omega2026

Harnessing Sequence Embedding and Ensemble Learning to Identify Antifungal Peptides with Low Hemolytic Risk.

Chung-Yen Lin, Wen-Chih Cheng, U-Lin Chen, Tzu-Tang Lin, Li-Hang Hsu, Yang-Hsin Shih, I-Hsuan Lu, Ying-Lien Chen, Shu-Hwa Chen

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chung-Yen LinInstitute of Information Science, Academia Sinica, Taipei 115, Taiwan.ORCID https://orcid.org/0000-0002-4733-9488
Wen-Chih ChengInstitute of Information Science, Academia Sinica, Taipei 115, Taiwan.
U-Lin ChenData Science Program, National Taiwan University, Taipei 10617, Taiwan.
Tzu-Tang LinCollege of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Li-Hang HsuDepartment of Plant Pathology and Microbiology, National Taiwan University, Taipei 10617, Taiwan.
Yang-Hsin ShihDepartment of Agricultural Chemistry, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei 10617, Taiwan.ORCID https://orcid.org/0000-0002-1326-0720
I-Hsuan LuInstitute of Information Science, Academia Sinica, Taipei 115, Taiwan.
Ying-Lien ChenDepartment of Plant Pathology and Microbiology, National Taiwan University, Taipei 10617, Taiwan.
Shu-Hwa ChenTMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 110, Taiwan.ORCID https://orcid.org/0009-0005-7094-9064

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of fungal infections represents a growing threat to human health, driven in part by the misuse of antibiotics and the rising incidence of resistance to conventional antifungal agents. Antifungal peptides (AFPs) have emerged as promising alternatives due to their diverse mechanisms of action and their relatively low propensity to develop resistance. To facilitate the systematic discovery of AFPs, we developed AI4AFP. This computational framework integrates curated antifungal peptide resources with advanced machine learning approaches to predict antifungal potential directly from peptide sequences. Using a comprehensive data set, we constructed a seven-model ensemble that combines multiple sequence encoding strategies, including ProtBERT-BFD, PC6, and Doc2Vec, with diverse learning algorithms, including random forests, support vector machines, convolutional neural networks, and fine-tuned BERT models. This ensemble demonstrated robust performance on an independent test set, achieving 0.94 in accuracy and 0.89 in Matthews correlation coefficient, outperforming existing AFP prediction methods. Importantly, the predicted AFP score is intended to reflect the general antifungal potential rather than species-specific potency. Experimental validation against representative fungal pathogens, including

Identifiers

PMID42146199
PMCPMC13177248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.